UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Huntington disease: natural history, biomarkers and prospects for therapeutics

Ross, CA; Aylward, EH; Wild, EJ; Langbehn, DR; Long, JD; Warner, JH; Scahill, RI; ... Tabrizi, SJ; + view all (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology , 10 204- 216. 10.1038/nrneurol.2014.24. Green open access

[thumbnail of Tabrizi_Wild_1_2014_NRN_HD_DRAFT_CR-RLMS-ST-EW_EDITS__1-13_14_(2).pdf]
Preview
PDF
Tabrizi_Wild_1_2014_NRN_HD_DRAFT_CR-RLMS-ST-EW_EDITS__1-13_14_(2).pdf

Download (481kB)
[thumbnail of 2013_NRN_Figure_1_10-11_13.pdf]
Preview
PDF
2013_NRN_Figure_1_10-11_13.pdf

Download (22kB)
[thumbnail of 2013_NRN_Figure_2_Track_36_month_data.pdf]
Preview
PDF
2013_NRN_Figure_2_Track_36_month_data.pdf

Download (484kB)
[thumbnail of 2013_NRN_Figure_3_TRACK_CAP_graphs_EW_2013-04-18ai.pdf]
Preview
PDF
2013_NRN_Figure_3_TRACK_CAP_graphs_EW_2013-04-18ai.pdf

Download (1MB)
[thumbnail of 2013_NRN_Figure_4_CAP_Registry+COHORT_plots-4.pdf]
Preview
PDF
2013_NRN_Figure_4_CAP_Registry+COHORT_plots-4.pdf

Download (297kB)
[thumbnail of 2013_NRN_Figure_5_Cell_Markers_EW_9-26-13.pdf]
Preview
PDF
2013_NRN_Figure_5_Cell_Markers_EW_9-26-13.pdf

Download (227kB)
[thumbnail of 2013_NRN_Figure_6_Circuits_CR.pdf] PDF
2013_NRN_Figure_6_Circuits_CR.pdf

Download (38kB)

Abstract

Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is caused by a single genetic mutation and is amenable to predictive genetic testing, with estimation of years to predicted onset, enabling the entire range of disease natural history to be studied. Structural neuroimaging biomarkers show that progressive regional brain atrophy begins many years before the emergence of diagnosable signs and symptoms of HD, and continues steadily during the symptomatic or 'manifest' period. The continued development of functional, neurochemical and other biomarkers raises hopes that these biomarkers might be useful for future trials of disease-modifying therapeutics to delay the onset and slow the progression of HD. Such advances could herald a new era of personalized preventive therapeutics. We describe the natural history of HD, including the timing of emergence of motor, cognitive and emotional impairments, and the techniques that are used to assess these features. Building on this information, we review recent progress in the development of biomarkers for HD, and potential future roles of these biomarkers in clinical trials.

Type: Article
Title: Huntington disease: natural history, biomarkers and prospects for therapeutics
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/nrneurol.2014.24
Publisher version: http://dx.doi.org/10.1038/nrneurol.2014.24
Language: English
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/1422728
Downloads since deposit
3,343Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item